deoxyepinephrine has been researched along with Coronary Disease in 5 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibopamine is a novel oral dopamine analogue with positive inotropy and diuretic effects." | 6.67 | [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. ( Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J, 1990) |
| "The hemodynamic effects of combined administration of ibopamine (Ib) (150 mg orally) with nitroprusside (NP) (50-150 micrograms/min intravenously) were compared with those of NP alone in 17 patients with severe congestive heart failure due to coronary artery disease (7 patients) or idiopathic cardiomyopathy (10 patients)." | 3.67 | Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy. ( Cicogna, R; Dei Cas, L; Fappani, A; Manca, C; Metra, M; Riva, S; Visioli, O, 1985) |
| "Ibopamine is a novel oral dopamine analogue with positive inotropy and diuretic effects." | 2.67 | [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. ( Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldberg, LI | 1 |
| Rajfer, SI | 1 |
| Rousseau, MF | 1 |
| Konstam, MA | 1 |
| Benedict, CR | 1 |
| Donckier, J | 1 |
| Galanti, L | 1 |
| Melin, J | 1 |
| Kinan, D | 1 |
| Ahn, S | 1 |
| Ketelslegers, JM | 1 |
| Pouleur, H | 1 |
| Wehling, M | 1 |
| Zimmermann, J | 1 |
| Weil, J | 1 |
| Gerzer, R | 1 |
| Theisen, K | 1 |
| Marchetti, G | 1 |
| Merlo, L | 1 |
| Dei Cas, L | 1 |
| Fappani, A | 1 |
| Riva, S | 1 |
| Metra, M | 1 |
| Cicogna, R | 1 |
| Manca, C | 1 |
| Visioli, O | 1 |
2 trials available for deoxyepinephrine and Coronary Disease
| Article | Year |
|---|---|
Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor.
Topics: Aged; Coronary Disease; Deoxyepinephrine; Dopamine Agents; Double-Blind Method; Down-Regulation; Dru | 1994 |
[Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
Topics: Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Coronary Disease; Cyclic GMP; De | 1990 |
3 other studies available for deoxyepinephrine and Coronary Disease
| Article | Year |
|---|---|
Sympathomimetic amines: potential clinical applications in ischemic heart disease.
Topics: Animals; Coronary Disease; Deoxyepinephrine; Dobutamine; Dogs; Dopamine; Heart Failure; Humans; Levo | 1982 |
Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs.
Topics: Animals; Cardiotonic Agents; Coronary Disease; Deoxyepinephrine; Dogs; Dopamine; Electrocardiography | 1986 |
Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Deoxyepinephrine; Dopami | 1985 |